Article Text

HIV surveillance in MENA: recent developments and results
  1. Ivana Bozicevic1,
  2. Gabriele Riedner2,
  3. Jesus Maria Garcia Calleja3
  1. 1World Health Organization Collaborating Centre for HIV Surveillance, University of Zagreb School of Medicine, Zagreb, Croatia
  2. 2World Health Organization Regional Office for Eastern Mediterranean, Cairo, Egypt
  3. 3World Health Organization, Geneva, Switzerland
  1. Correspondence to Dr Ivana Bozicevic, World Health Organization Collaborating Centre for HIV Surveillance, University of Zagreb School of Medicine, Rockefellerova 4, Zagreb 10 000, Croatia; Ivana.Bozicevic{at}lshtm.ac.uk

Abstract

Objectives To provide an overview of the current level of development and results from the national HIV surveillance systems of the 23 countries of the Middle East and North Africa (MENA), and to assess the quality of HIV surveillance systems in the period 2007–2011.

Methods A questionnaire was used to collect the information about the structure, activities and the results of HIV surveillance systems from the National AIDS Programmes. Assessment of the quality was based on four indicators: timeliness of data collection, appropriateness of populations under surveillance, consistency of the surveillance sites and groups measured over time, and coverage of the surveillance system.

Results Only in four countries did surveillance systems enable assessment of epidemic trends in the same populations and locations over time, such as in pregnant women (Morocco, Iran), injecting drug users (Iran, Pakistan), female sex workers (Djibouti, Morocco) and male sex workers (Pakistan). There is increasing evidence of HIV infection being firmly established in at least one of the populations most at risk of HIV in nine MENA countries, while lower risk populations show elevated HIV prevalence in South Sudan, Djibouti and some parts of Somalia.

Conclusions The performance of HIV surveillance systems in several of the MENA countries has improved in recent years. The extent of HIV epidemics in the populations most at risk of HIV is still largely unknown in 10 countries. Multiple data sources that most of the countries still lack would enable indirectly estimation not only of the patterns of HIV epidemics but also the effectiveness of HIV responses.

  • Surveillance
  • HIV
  • Epidemiology (Clinical)
  • Injecting Drug Use
  • Sexual Behaviour

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

  • Arabic Abstract translation

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement: